Search / Trial NCT00000389

Treatment for Anxiety in Children

Launched by NATIONAL INSTITUTE OF MENTAL HEALTH (NIMH) · Nov 2, 1999

Trial Information

Current as of December 08, 2024

Completed

Keywords

Adolescence Anxiety Disorders Child Female Fluvoxamine Human Male Serotonin Uptake Inhibitors Anxiety Disorders *Drug Therapy Fluvoxamine *Therapeutic Use Serotonin Uptake Inhibitors *Therapeutic Use

ClinConnect Summary

To evaluate fluvoxamine in the treatment of children and adolescents with anxiety disorders.

Fluvoxamine is a serotonin reuptake inhibitor that is FDA-approved for the treatment of obsessive-compulsive disorder (OCD) in adults and children. Anxiety disorders other than OCD are very common in youth and are not always responsive to psychosocial therapies. Fluvoxamine is an alternative treatment.

After a 3-week period of evaluation, patients meeting study entry criteria are randomized to receive either fluvoxamine or placebo for 8 weeks. After this double-blind phase, patients can enter a 4-...

Gender

ALL

Eligibility criteria

  • - Patients must have: DSM -IV diagnosis of generalized anxiety disorder, social phobia, or separation anxiety.

Trial Officials

Laurence Greenhill, MD

Principal Investigator

Mark Riddle, MD

Principal Investigator

About National Institute Of Mental Health (Nimh)

The National Institute of Mental Health (NIMH) is a leading federal agency dedicated to advancing the understanding and treatment of mental health disorders through innovative research and clinical trials. As part of the National Institutes of Health (NIH), NIMH focuses on a broad spectrum of mental health issues, including mood disorders, anxiety disorders, schizophrenia, and developmental disorders. By fostering collaboration among researchers, clinicians, and the community, NIMH aims to translate scientific discoveries into effective interventions and improve mental health outcomes for individuals across the lifespan. Through its commitment to rigorous research methodologies and ethical standards, NIMH plays a pivotal role in shaping the future of mental health care and policy.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials